Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000101

Drug Information
SynonymsI14-0747; Lorastine; Talorat Dy; Lorfast; 4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester; D00364; L 9664; NCGC00023125-06; Alavert, Claritin, Loratadine; DivK1c_000792; Loratyne; Loranox; EU-0100680; Loraver; Allertidin; Sch 29851; Sch29851; NCGC00023125-05; Loracert; D017336; Lergy; Tadine; Sinhistan Dy; HMS502H14; Loratadinum [Latin]; ZINC00537931; 1-Piperidenecarboxylic acid, 4-(8-chloro-5,6-duhydro-11H-benzo [5,6]cyclohepta[1,2-b]-pyridin-11-ylidene)-, ethyl ester; KBio1_000792; 1-piperidinecarboxylic acid,4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-,ethyl ester; Restamine; NINDS_000792; NCGC00015619-10; Spectrum2_001584; BIDD:GT0198; Spectrum5_001650; Claritin D; C22H23ClN2O2; Loradex; Lowadina; Bonalerg; Oprea1_027965; Sanelor; Lopac-L-9664; Loratadine [USAN:BAN:INN]; KBio2_004544; Loratadina; Clarinase; KBio2_007112; Claritin reditab; Anhissen; LS-114660; AC-2086; Claratyne; Pylor; NCGC00023125-04; Lopac0_000680; HSDB 3578; SAM001246987; BRD-K82795137-001-02-3; BSPBio_002300; Optimin; MLS000069647; HMS2090O18; Claritin Hives Relief Reditab; Zeos; Tocris-1944; Clarityne-D; 79794-75-5; BRD-K82795137-001-10-6; STK574925; Clarinase Reperabs; NSC721075; Civeran; NCGC00023125-02; Claritin Reditabs; KBio2_001976; Loratadine (JAN/USAN/INN); L0223; IDI1_000792; Histaloran; CPD000058255; Fristamin; KBio3_001520; Loratidine; HMS2051G11; NCGC00015619-06; Claritine; Rinomex; Loratadine Wyeth Brand; Loratadinum; Lisino; Versal; loratadine; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester; Claritin (TN); SMR000058255; Sensibit; Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylate; CID3957; ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate; L9664_SIGMA; 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester; Lorantis; Clarityne; Alerpriv; Spectrum3_000740; Spectrum4_000177; NCI60_041473; Clarityn; Sch-29851; Alavert; Sohotin; Biloina; KBioSS_001976; Alarin; DB00455; Nularef; Roletra; Spectrum_001496; BB_SC-2109; Rhinase; NCGC00023125-07; KBioGR_000693; NCGC00015619-02; TL8005389; HMS2093I15; Bedix Loratadina; Clarium; Aerotina; Lertamine; Children's Claritin; MolPort-002-507-846; AC1L1H3E; Loritine; Claratyne Cold; Velodan; Wyeth Brand of Loratadine; S1358_Selleck; Loratadina [Spanish]; MLS000758260; Claritin Hives Relief; Polaratyne; 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester; Loratadine Redidose; Loradif; NCGC00015619-01; MLS001148466; SPBio_001548; Lesidas; Claritin; Claratyne Decongestant; CHEMBL998; SPECTRUM1503712; UNII-7AJO3BO7QN; L000667; 1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester; Clarityne Dy Repetabs    
Trade NameClaritin; Claritin-D; Claritine; Clarityn; Clarityne; Fristamin; Lorfast; Lomilan; Flonidan; Symphoral; Roletra; Rinolan; AllergyX; Alavert; Tidilor    
CompanySchering-Plough Corporation    
IndicationAllergiesApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntihistamines    
CAS NumberCAS 79794-75-5
PubChem Compound IDCID 3957.    
PubChem Substance IDSID 192028.    
SuperDrug ATC IDR06AX13;    
SuperDrug CAS ID079794755;    
TargetHistamine H1 receptorAntagonist[2][3][4]
Ref 1Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Clin Ther. 2007 Sep;29(9):1795-802. To Reference
Ref 2Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Jan;23(2):63-6. To Reference
Ref 3Second-generation antihistamines: a comparative review. Drugs. 1999 Jan;57(1):31-47. To Reference
Ref 4Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5. Br J Pharmacol. 1997 Nov;122(5):796-8. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543